Correlation Between ESSA Pharma and Durect

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ESSA Pharma and Durect at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ESSA Pharma and Durect into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ESSA Pharma and Durect, you can compare the effects of market volatilities on ESSA Pharma and Durect and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ESSA Pharma with a short position of Durect. Check out your portfolio center. Please also check ongoing floating volatility patterns of ESSA Pharma and Durect.

Diversification Opportunities for ESSA Pharma and Durect

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between ESSA and Durect is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding ESSA Pharma and Durect in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Durect and ESSA Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ESSA Pharma are associated (or correlated) with Durect. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Durect has no effect on the direction of ESSA Pharma i.e., ESSA Pharma and Durect go up and down completely randomly.

Pair Corralation between ESSA Pharma and Durect

Given the investment horizon of 90 days ESSA Pharma is expected to under-perform the Durect. In addition to that, ESSA Pharma is 1.71 times more volatile than Durect. It trades about -0.11 of its total potential returns per unit of risk. Durect is currently generating about -0.06 per unit of volatility. If you would invest  134.00  in Durect on September 28, 2024 and sell it today you would lose (37.00) from holding Durect or give up 27.61% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

ESSA Pharma  vs.  Durect

 Performance 
       Timeline  
ESSA Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ESSA Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Durect 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Durect has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

ESSA Pharma and Durect Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ESSA Pharma and Durect

The main advantage of trading using opposite ESSA Pharma and Durect positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ESSA Pharma position performs unexpectedly, Durect can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Durect will offset losses from the drop in Durect's long position.
The idea behind ESSA Pharma and Durect pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume